RESMED INC - Common Stock (RMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
RMD on NYSE
Shares outstanding
146,467,184
Price per share
$257.61
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
96,207,332
Total reported value
$23,172,192,306
% of total 13F portfolios
0.01%
Share change
+4,235,509
Value change
+$984,224,091
Number of holders
924
Price from insider filings
$257.61
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of RESMED INC - Common Stock (RMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 14% $5,476,630,365 20,007,417 The Vanguard Group 30 Sep 2025

As of 31 Dec 2025, 924 institutional investors reported holding 96,207,332 shares of RESMED INC - Common Stock (RMD). This represents 66% of the company’s total 146,467,184 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of RESMED INC - Common Stock (RMD) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 13% 18,882,403 -0.83% 0.07% $4,548,204,411
BlackRock, Inc. 8.4% 12,348,652 +0.58% 0.05% $2,974,419,664
STATE STREET CORP 4.5% 6,625,408 +1.2% 0.05% $1,595,862,025
Bank of New York Mellon Corp 3.3% 4,890,654 +7.4% 0.21% $1,178,011,765
GEODE CAPITAL MANAGEMENT, LLC 2.9% 4,302,906 +1.2% 0.06% $1,032,876,781
MORGAN STANLEY 2% 2,891,697 +25% 0.04% $696,523,345
Invesco Ltd. 1.3% 1,951,933 -7.4% 0.07% $470,162,194
NORTHERN TRUST CORP 1.2% 1,785,384 +5.2% 0.05% $430,045,444
FIRST TRUST ADVISORS LP 1% 1,517,592 +241% 0.27% $365,542,340
DEUTSCHE BANK AG\ 0.97% 1,413,477 +126% 0.11% $340,464,204
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.75% 1,103,459 +3.4% 0.04% $265,790,169
Swedbank AB 0.75% 1,102,476 +103% 0.26% $265,553,393
NORDEA INVESTMENT MANAGEMENT AB 0.74% 1,084,996 +37% 0.23% $262,026,535
NORGES BANK 0.71% 1,034,037 0.03% $249,068,492
Legal & General Group Plc 0.68% 992,527 +3.6% 0.05% $239,069,978
DIMENSIONAL FUND ADVISORS LP 0.67% 980,544 +16% 0.05% $236,202,810
GOLDMAN SACHS GROUP INC 0.67% 979,087 +14% 0.03% $235,832,740
UBS Group AG 0.62% 906,415 +3.8% 0.04% $218,328,181
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.57% 836,428 -7.8% 0.04% $201,470,413
BANK OF AMERICA CORP /DE/ 0.57% 831,024 +0.9% 0.01% $200,168,862
PRICE T ROWE ASSOCIATES INC /MD/ 0.53% 770,414 -0.23% 0.02% $185,571,000
JPMORGAN CHASE & CO 0.4% 585,608 -5.2% 0.01% $141,055,545
Tandem Investment Advisors, Inc. 0.34% 500,145 -1% 4.5% $120,469,926
Caisse de depot et placement du Quebec 0.33% 480,642 -15% 0.2% $115,772,239
CAPTRUST FINANCIAL ADVISORS 0.33% 480,058 -11% 0.22% $115,631,542

Institutional Holders of RESMED INC - Common Stock (RMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 96,207,332 $23,172,192,306 +$984,224,091 $240.87 924
2025 Q3 91,514,864 $25,041,067,865 -$133,993,892 $273.73 938
2025 Q2 92,309,428 $23,802,163,537 -$234,889,533 $258.00 911
2025 Q1 93,341,270 $20,873,665,746 +$659,205,153 $223.85 872
2024 Q4 90,103,150 $20,611,027,939 +$523,118,005 $228.69 863
2024 Q3 86,823,807 $21,178,183,309 +$357,448,956 $244.12 792
2024 Q2 85,413,001 $16,344,246,847 +$454,535,216 $191.42 768
2024 Q1 82,914,769 $16,411,147,126 +$513,359,778 $198.03 710
2023 Q4 80,394,822 $13,829,283,421 -$1,271,808,453 $172.02 680
2023 Q3 87,735,817 $12,964,369,891 -$1,617,256,395 $147.87 648
2023 Q2 95,075,328 $20,771,183,152 -$111,688,592 $218.50 724
2023 Q1 95,323,306 $20,870,559,574 +$76,827,102 $218.99 665
2022 Q4 95,570,997 $19,893,153,622 -$213,631,417 $208.13 717
2022 Q3 96,528,325 $21,085,043,390 -$40,809,623 $218.30 650
2022 Q2 96,423,808 $20,247,886,410 -$216,827,167 $209.63 661
2022 Q1 97,272,612 $23,607,128,509 +$638,048,061 $242.51 658
2021 Q4 94,533,097 $24,611,319,237 -$550,619,558 $260.48 703
2021 Q3 96,265,199 $25,370,506,829 -$115,406,017 $263.55 673
2021 Q2 96,700,199 $23,835,730,320 -$548,687,648 $246.52 650
2021 Q1 99,033,646 $19,213,495,080 -$384,053,397 $194.02 649
2020 Q4 101,297,957 $21,523,684,165 +$125,179,911 $212.56 652
2020 Q3 100,513,676 $17,230,325,953 -$286,391,481 $171.43 612
2020 Q2 102,006,987 $19,585,421,181 +$701,386,093 $192.00 567
2020 Q1 98,435,082 $14,502,972,264 +$119,165,301 $147.29 574
2019 Q4 97,640,442 $15,128,001,356 +$142,829,575 $154.97 551
2019 Q3 96,630,375 $13,051,505,290 +$38,434,738 $135.11 514
2019 Q2 96,365,742 $11,754,959,118 +$23,486,040 $122.03 475
2019 Q1 97,619,409 $10,147,859,923 -$14,207,588 $103.97 468
2018 Q4 97,569,996 $11,099,337,871 +$397,513,543 $113.87 489
2018 Q3 94,081,151 $10,848,844,708 +$178,170,189 $115.34 486
2018 Q2 92,503,328 $9,581,445,253 +$226,242,346 $103.58 455
2018 Q1 90,228,934 $8,883,079,877 +$143,625,612 $98.47 435
2017 Q4 89,322,328 $7,564,180,997 +$29,233,715 $84.69 410
2017 Q3 88,883,200 $6,839,668,471 +$166,333,622 $76.96 359
2017 Q2 86,773,703 $6,755,702,862 +$42,211,359 $77.87 335
2017 Q1 86,833,338 $6,248,639,244 +$813,666,355 $71.97 368
2016 Q4 88,072,867 $5,464,641,164 -$131,915,963 $62.05 356
2016 Q3 89,994,221 $5,828,633,461 +$197,606,819 $64.79 368
2016 Q2 86,958,278 $5,499,043,282 +$226,844,283 $63.23 355
2016 Q1 83,494,592 $4,825,081,452 +$24,464,544 $57.82 365
2015 Q4 82,814,635 $4,446,599,092 +$286,786,392 $53.69 346
2015 Q3 77,270,412 $3,927,210,578 +$122,197,423 $50.96 310
2015 Q2 74,586,620 $4,203,538,985 +$12,963,111 $56.37 310
2015 Q1 73,509,048 $5,271,836,683 -$59,419,105 $71.78 323
2014 Q4 74,749,965 $4,194,016,041 +$85,626,962 $56.06 302
2014 Q3 72,751,035 $3,584,815,417 -$144,765,288 $49.27 297
2014 Q2 75,588,962 $3,827,465,671 -$207,528,760 $50.63 308
2014 Q1 80,134,321 $3,581,405,050 +$1,484,371 $44.69 314